Literature DB >> 25564267

Agraphia caused by acute right parietal infarction.

Manyong Lee1, Mee Kyung Suh2, Myung Hyun Lee1, Jin Soo Lee1, So Young Moon3.   

Abstract

Injury in the dominant language hemisphere typically leads to agraphia, however we report a patient with agraphia after injury to the right angular gyrus. A 71-year-old Korean woman presented with the complaint of an inability to write for the last 7 days. The patient had been illiterate for most of her life, but had started learning to write Hangul, the Korean alphabet, at a welfare center 3 years ago. On language screening she was unable to write although she could read, and other language functions showed no abnormalities. Brain MRI showed acute infarction in the right angular gyrus. Her writing patterns displayed features of surface agraphia, indicative of phoneme-to-grapheme conversion with phonetic writing of targets. Additionally, she manifested visual errors. A functional MRI indicated that her left hemisphere was language dominant. This patient experienced agraphia resulting from pure impairment of visuo-constructive function after acute infarction in the right angular gyrus.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Agraphia; Angular gyrus; Hangul; Parietal; Right; Spatial

Mesh:

Year:  2015        PMID: 25564267     DOI: 10.1016/j.jocn.2014.09.023

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Could pure agraphia be the only sign of stroke? Lessons from two case reports.

Authors:  L Billeri; A Naro; A Manuli; R S Calabro
Journal:  J Postgrad Med       Date:  2021 Apr-Jun       Impact factor: 1.476

2.  Delineating the cognitive-neural substrates of writing: a large scale behavioral and voxel based morphometry study.

Authors:  Haobo Chen; Xiaoping Pan; Wai-Ling Bickerton; Johnny King Lau; Jin Zhou; Beinan Zhou; Lara Harris; Pia Rotshtein
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.